Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 232 | 717 | 794 | 826 | 924 |
| Other Working Capital | 6,825 | -2,124 | -2,699 | -69 | 732 |
| Other Operating Activity | -76 | 1,013 | 390 | 757 | 449 |
| Operating Cash Flow | $6,981 | $-394 | $-1,515 | $1,515 | $2,106 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 147 | -457 | -469 | -207 | -765 |
| Other Investing Activity | 96 | 83 | -205 | 138 | -7 |
| Investing Cash Flow | $243 | $-374 | $-674 | $-69 | $-771 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -709 | -667 | 15 | -757 | -515 |
| Other Financing Activity | -1,227 | 288 | 334 | 207 | 1,887 |
| Financing Cash Flow | $-1,936 | $-379 | $348 | $-551 | $1,372 |
| Beginning Cash Position | -1,991 | -743 | 964 | 138 | -3,881 |
| End Cash Position | 3,298 | -1,991 | -743 | 964 | 138 |
| Net Cash Flow | $5,289 | $-1,147 | $-1,840 | $895 | $2,707 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,981 | -394 | -1,515 | 1,515 | 2,106 |
| Capital Expenditure | N/A | -457 | -469 | -207 | -766 |
| Free Cash Flow | 6,981 | -851 | -1,983 | 1,308 | 1,340 |